BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38676718)

  • 21. BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.
    Brastianos PK; Twohy E; Geyer S; Gerstner ER; Kaufmann TJ; Tabrizi S; Kabat B; Thierauf J; Ruff MW; Bota DA; Reardon DA; Cohen AL; De La Fuente MI; Lesser GJ; Campian J; Agarwalla PK; Kumthekar P; Mann B; Vora S; Knopp M; Iafrate AJ; Curry WT; Cahill DP; Shih HA; Brown PD; Santagata S; Barker FG; Galanis E
    N Engl J Med; 2023 Jul; 389(2):118-126. PubMed ID: 37437144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy.
    Cipri S; Del Baldo G; Fabozzi F; Boccuto L; Carai A; Mastronuzzi A
    Front Oncol; 2023; 13():1204829. PubMed ID: 37397394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
    Mellinghoff IK; van den Bent MJ; Blumenthal DT; Touat M; Peters KB; Clarke J; Mendez J; Yust-Katz S; Welsh L; Mason WP; Ducray F; Umemura Y; Nabors B; Holdhoff M; Hottinger AF; Arakawa Y; Sepulveda JM; Wick W; Soffietti R; Perry JR; Giglio P; de la Fuente M; Maher EA; Schoenfeld S; Zhao D; Pandya SS; Steelman L; Hassan I; Wen PY; Cloughesy TF;
    N Engl J Med; 2023 Aug; 389(7):589-601. PubMed ID: 37272516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformal Radiation Therapy for Ependymoma at Age ≤3 Years: A 25-Year Experience.
    Howe GN; Edmonston DY; Dirks GC; Boop FA; Merchant TE
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):869-877. PubMed ID: 36690160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early experience with targeted therapy as a first-line adjuvant treatment for pediatric low-grade glioma.
    Leclair NK; Lambert W; Roche K; Gillan E; Gell JJ; Lau CC; Wrubel G; Knopf J; Amin S; Anderson M; Martin JE; Bookland MJ; Hersh DS
    Neurosurg Focus; 2022 Dec; 53(6):E15. PubMed ID: 36455272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric
    Bouffet E; Geoerger B; Moertel C; Whitlock JA; Aerts I; Hargrave D; Osterloh L; Tan E; Choi J; Russo M; Fox E
    J Clin Oncol; 2023 Jan; 41(3):664-674. PubMed ID: 36375115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laser Interstitial Thermal Therapy for First-Line Treatment of Surgically Accessible Recurrent Glioblastoma: Outcomes Compared With a Surgical Cohort.
    Fadel HA; Haider S; Pawloski JA; Zakaria HM; Macki M; Bartlett S; Schultz L; Robin AM; Kalkanis SN; Lee IY
    Neurosurgery; 2022 Nov; 91(5):701-709. PubMed ID: 35986677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
    Butt OH; Zhou AY; Huang J; Leidig WA; Silberstein AE; Chheda MG; Johanns TM; Ansstas G; Liu J; Talcott G; Nakiwala R; Shimony JS; Kim AH; Leuthardt EC; Tran DD; Campian JL
    Neurooncol Adv; 2021; 3(1):vdab164. PubMed ID: 34988450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Focused Ultrasound Tumor Ablation to Brain Blood Barrier Opening for High Grade Glioma: A Systematic Review.
    Paun L; Moiraghi A; Jannelli G; Nouri A; DiMeco F; Pallud J; Meling TR; Momjian S; Schaller K; Prada F; Migliorini D
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients.
    Rincon-Torroella J; Khela H; Bettegowda A; Bettegowda C
    J Neurooncol; 2022 Jan; 156(1):33-48. PubMed ID: 34613580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
    Ahrendsen JT; Sinai C; Meredith DM; Malinowski SW; Cooney TM; Bandopadhayay P; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2021 Nov; 80(11):1052–1059. PubMed ID: 34580728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trametinib therapy for children with neurofibromatosis type 1 and life-threatening plexiform neurofibroma or treatment-refractory low-grade glioma.
    Ronsley R; Hounjet CD; Cheng S; Rassekh SR; Duncan WJ; Dunham C; Gardiner J; Ghag A; Ludemann JP; Wensley D; Rehmus W; Sargent MA; Hukin J
    Cancer Med; 2021 Jun; 10(11):3556-3564. PubMed ID: 33939292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
    Fangusaro J; Onar-Thomas A; Poussaint TY; Wu S; Ligon AH; Lindeman N; Campagne O; Banerjee A; Gururangan S; Kilburn LB; Goldman S; Qaddoumi I; Baxter P; Vezina G; Bregman C; Patay Z; Jones JY; Stewart CF; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
    Neuro Oncol; 2021 Oct; 23(10):1777-1788. PubMed ID: 33631016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review.
    Chen C; Lee I; Tatsui C; Elder T; Sloan AE
    J Neurooncol; 2021 Feb; 151(3):429-442. PubMed ID: 33611709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
    Wright KD; Yao X; London WB; Kao PC; Gore L; Hunger S; Geyer R; Cohen KJ; Allen JC; Katzenstein HM; Smith A; Boklan J; Nazemi K; Trippett T; Karajannis M; Herzog C; Destefano J; Direnzo J; Pietrantonio J; Greenspan L; Cassidy D; Schissel D; Perentesis J; Basu M; Mizuno T; Vinks AA; Prabhu SP; Chi SN; Kieran MW
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28787. PubMed ID: 33140540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging indications for stereotactic laser interstitial thermal therapy in pediatric neurosurgery.
    Remick M; McDowell MM; Gupta K; Felker J; Abel TJ
    Int J Hyperthermia; 2020 Jul; 37(2):84-93. PubMed ID: 32672117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National Trends and Factors Predicting Outcomes Following Laser Interstitial Thermal Therapy for Brain Lesions: Nationwide Inpatient Sample Analysis.
    Sharma M; Ugiliweneza B; Wang D; Boakye M; Andaluz N; Neimat J; Mohammadi A; Barnett GH; Williams BJ
    World Neurosurg; 2020 Jul; 139():e88-e97. PubMed ID: 32251808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance-guided stereotactic laser ablation therapy for the treatment of pediatric brain tumors: a multiinstitutional retrospective study.
    Arocho-Quinones EV; Lew SM; Handler MH; Tovar-Spinoza Z; Smyth M; Bollo R; Donahue D; Perry MS; Levy ML; Gonda D; Mangano FT; Storm PB; Price AV; Couture DE; Oluigbo C; Duhaime AC; Barnett GH; Muh CR; Sather MD; Fallah A; Wang AC; Bhatia S; Patel K; Tarima S; Graber S; Huckins S; Hafez DM; Rumalla K; Bailey L; Shandley S; Roach A; Alexander E; Jenkins W; Tsering D; Price G; Meola A; Evanoff W; Thompson EM; Brandmeir N;
    J Neurosurg Pediatr; 2020 Mar; 26(1):13-21. PubMed ID: 32217793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbon Ion Therapy: A Modern Review of an Emerging Technology.
    Malouff TD; Mahajan A; Krishnan S; Beltran C; Seneviratne DS; Trifiletti DM
    Front Oncol; 2020; 10():82. PubMed ID: 32117737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.